Tara Carlisle, MD, PhD, University of Colorado, discusses how coordinated care efforts and frequent safety monitoring are ...

When pharmacists practice in value-based care settings, their impact on arrhythmia management expands far beyond medication ...

Collaborative ACOs and value-based care models help include rural providers, achieving shared savings despite resource limitations and inappropriate spending benchmarks. ACOs serving patients with ...

An increased risk of local-regional recurrence in stage 1 non–small cell lung cancer (NSCLC) was found in individuals who needed a percutaneous transthoracic needle biopsy (PTNB) prior to their ...

Panelists discuss the therapeutic landscape for metastatic colorectal cancer once patients progress to third-line treatment.

The new report from the WHO Global Antimicrobial Resistance and Use Surveillance System is its most extensive, with estimates ...

Providers want payer contracts that support systems and practices enabling patients to receive higher-quality, lower-cost care by establishing the necessary infrastructure, care patterns, drug ...

The LINKER-SMM1 trial shows promising results for linvoseltamab in treating high-risk smoldering multiple myeloma with a favorable safety profile, notes Paula Rodríguez-Otero, MD, PhD.

Combination therapies such as clindamycin and rifampin, Mayo said, are the most heavily researched combination therapy for HS. Triple therapies that include rifampin also consist of moxifloxacin and ...

Vivek Subbiah, MD, highlights key topics at the 50th European Society for Medical Oncology (ESMO) Congress, including the rise of tumor-agnostic therapies and the use of artificial intelligence (AI) ...

With the recent observance of World Arthritis Day, stakeholders highlight persistent barriers to coordinated, affordable care ...

Research highlights the need for diverse data on drug efficacy in atopic dermatitis to address barriers to treatment for patients with skin of color, notes Elain Siegfried, MD.